Search research articles
Contact Us
Filters
Showing results (81-90 of 85) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 85 results.
European Urology
|
January 1, 1983
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial
G Pizzocaro, G Di Fronzo, L Piva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
J-L Pico, G Rosti, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
A Necchi, L Mariani, M Di Nicola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
H J Schmoll, R Souchon, S Krege, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 85) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 85 results.
European Urology
|
January 1, 1983
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial
G Pizzocaro, G Di Fronzo, L Piva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
J-L Pico, G Rosti, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
A Necchi, L Mariani, M Di Nicola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
H J Schmoll, R Souchon, S Krege, et al.
Page
of 9